With a robust scientific-phase pipeline, Agenus harnesses a mix of proprietary antibody platforms, which include Retrocyte Display screen™ and SECANT®, and progressive mobile therapy strategies, positioning alone as being a essential contributor from the biotechnology and immunotherapy arena.Maintaining independence and editorial liberty is crit